Synthesis of Nucleosides and Non-nucleosides Based 4,6-disubstituted-2- oxo-dihydropyridine-3-carbonitriles as Antiviral Agents-Reference-Cited by-同舟云学术

Synthesis of Nucleosides and Non-nucleosides Based 4,6-disubstituted-2- oxo-dihydropyridine-3-carbonitriles as Antiviral Agents

Published:2018-11-02 Issue:8 Volume:14 Page:791-808
ISSN:1573-4064
Container-title:Medicinal Chemistry
language:en
Short-container-title:MC

Author:

Ibrahim Tarek S.¹,El-Sayed Hassan A.²,Khayat Maan T.¹,AL-Mahmoudy Amany M.M.³,Moustafa Ahmed H.²,El-Deen Ayat K.S.²,Rostom Sherif A.F.⁴,Panda Siva S.⁵

Affiliation:

1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia

2. Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, Egypt

3. Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt

4. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, 21521, Egypt

5. Department of Chemistry & Physics, Augusta University, Augusta, GA 30912, United States

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Perspectives of 2‐alkoxy‐3‐Cyanopyridine Scaffolds: An Up‐to‐Date Review;ChemistrySelect;2024-05-24

2. N-Substituted dihydropyridines as promising EGFR tyrosine kinase inhibitors against breast cancer: Design, synthesis, biological evaluation, docking, and molecular dynamics simulations;Results in Chemistry;2024-01

3. Anticancer potential of novel symmetrical and asymmetrical dihydropyridines against breast cancer via EGFR inhibition: molecular design, synthesis, analysis and screening;RSC Advances;2024

4. K₂CO₃-nanoparticles catalyzed the synthesis of 3-arylidine imidazo[1,2-c]pyrimidine candidates: Cytotoxic activity and docking study;Synthetic Communications;2023-06-11

5. A review: Biological activities of novel cyanopyridine derivatives;Archiv der Pharmazie;2023-04-07